McCarthy Kateri, Bondy Carolyn A
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA, Tel.: +1 301 496 4686.
Expert Rev Endocrinol Metab. 2008;3(6):771-775. doi: 10.1586/17446651.3.6.771.
This article reviews current patterns of ascertainment, clinical characteristics and quality of care for girls with Turner syndrome, based on a cohort of 100 girls (aged 7-17 years) prospectively evaluated at the National Institute of Child Health since 2001. Approximately 25% were diagnosed prenatally or at birth owing to webbed neck and other features typical of fetal lymphedema, few were diagnosed during early childhood, with the majority undiagnosed until age 9 years or older. Major clinical features included thyroid autoimmunity (51%), congenital cardiovascular anomalies (44%), liver abnormalities (36%), hypertension (34%), hearing loss (30%) and renal anomalies (18%). Of the group, 75% were being or had been treated with growth hormone. These girls were an average of 5 cm taller and significantly less obese than the untreated group. We discuss new guidelines for the initiation of puberty and urgent research needed to promote the health and longevity of girls suffering from Turner syndrome as they become adults.
本文回顾了特纳综合征女孩的当前确诊模式、临床特征和护理质量,该回顾基于自2001年以来在美国国立儿童健康研究所前瞻性评估的100名女孩(年龄7至17岁)队列。约25%的女孩在产前或出生时因蹼颈及其他典型的胎儿淋巴水肿特征而被诊断,少数在幼儿期被诊断,大多数直到9岁或更晚才被诊断。主要临床特征包括甲状腺自身免疫(51%)、先天性心血管异常(44%)、肝脏异常(36%)、高血压(34%)、听力损失(30%)和肾脏异常(18%)。该组中,75%正在接受或曾接受生长激素治疗。这些女孩比未治疗组平均高5厘米,肥胖程度也显著更低。我们讨论了青春期启动的新指南以及促进特纳综合征女孩成年后健康和长寿所需的迫切研究。